From Vaccines to Baking Ingredients: The Digest’s 2020 Multi-Slide Guide to Amyris’s Q2

0
174

Earlier this week, Amyris made news with their sugarcane-derived squalene COVID-19 vaccine adjuvant. But how was their Q2 2020 considering all the challenges so far this year?

With a focus on high growth consumer brands, scientific and commercial collaborations, supply chain organization, and more, Amyris had a strong Q2 especially with their record revenue for their consumer brands. How their portfolio has shifted in this new world, strategic priorities, operations updates, 2020 outlook and more.



Original Source